2026-05-07 · non-surgical, endoscopic, procedures
Written by Nora Kim
Nora Kim covers medical and surgical weight loss options, GLP-1 therapies, and evidence-based supplements. She focuses on explaining clinical research, safety considerations, and practical next steps so readers can discuss treatment choices with their care teams.
Endoscopic Sleeve Gastroplasty
Who this is for / not for
Good fit if:
- You have a BMI typically in the 30–40 range and want a less invasive option than surgery.
- You prefer an endoscopic approach with shorter recovery.
- You can commit to nutrition coaching and follow-up visits.
Not a fit if:
- You have prior stomach surgery, large hiatal hernia, or bleeding risks that complicate endoscopy.
- You need the highest possible weight loss and are a better candidate for surgery.
- You cannot commit to structured follow-up and lifestyle changes.
What it is (plain-language definition)
Endoscopic sleeve gastroplasty (ESG) is a minimally invasive weight loss procedure performed through the mouth without external incisions. Using an endoscope and suturing device, a physician reduces the size of the stomach by creating internal folds. This smaller stomach limits food intake and slows gastric emptying, helping people feel full sooner. ESG is considered a middle ground between lifestyle programs and bariatric surgery.
Evidence in this article draws on peer-reviewed clinical research, including findings from this study and this trial.
How it works (or how it’s done)
Endoscopic sleeve gastroplasty (ESG) is a minimally invasive weight loss procedure performed through the mouth without external incisions. Using an endoscope and suturing device, a physician reduces the size of the stomach by creating internal folds.
Benefits vs. limitations
- Benefits: Most studies show about 15–20% total body weight loss by 12–18 months, with the fastest change in the first 6 months.
- Limitations: Nausea, vomiting, bleeding, or perforation can occur, and reflux may worsen in some patients.
Expected outcomes (realistic results)
Most studies show about 15–20% total body weight loss by 12–18 months, with the fastest change in the first 6 months. Some data suggest 12–15% loss can be maintained at 2–3 years when follow-up and dietary habits stay consistent, though regain is possible if behaviors drift.
Risks, side effects, or downsides
- Risks: Nausea, vomiting, bleeding, or perforation can occur, and reflux may worsen in some patients.
- Trade-offs: It is less invasive than surgery but typically delivers less weight loss and may require repeat procedures.
- Monitoring: Early follow-up focuses on hydration and diet progression, with ongoing checks for reflux and nutritional status.
Who is eligible for endoscopic sleeve gastroplasty?
Patient eligibility for endoscopic sleeve gastroplasty depends on BMI, prior weight loss attempts, overall health, and the ability to commit to long-term lifestyle changes. Most programs follow these candidacy criteria:
BMI criteria
- BMI 30 to 40 is the most common range for ESG. This is the sweet spot where the procedure has the strongest evidence and where many bariatric surgery programs would not yet recommend a surgical sleeve.
- BMI 27 to 30 with weight-related conditions (such as type 2 diabetes, hypertension, or sleep apnea) may also qualify at some centers.
- BMI above 40 is not an automatic disqualifier, but a sleeve gastrectomy or gastric bypass is often discussed first because it typically delivers more weight loss.
Patients who don’t qualify for or want traditional bariatric surgery
- Patients whose BMI is below the surgical threshold but who have not lost enough weight with diet, exercise, or medications.
- Patients who decline laparoscopic surgery because of recovery time, scarring, anesthesia risk, or concerns about a permanent change to stomach anatomy.
- Patients with operational or scheduling constraints (caregivers, certain occupations) who need a faster return to daily life than surgical bariatric procedures allow.
Failed prior weight loss attempts
Most ESG programs expect documented evidence that less invasive approaches have not produced lasting results. That usually means:
- A structured attempt at diet and exercise, often through a medical weight loss program or registered-dietitian-led plan.
- A trial of GLP-1 or other prescription medications when appropriate, with weight regain after stopping or insufficient response.
- A pattern of weight cycling rather than a single short attempt.
Medical conditions that may disqualify candidates
- Prior stomach surgery (sleeve, bypass, fundoplication) or large hiatal hernia, which can interfere with suture placement.
- Active gastrointestinal disease such as severe reflux, peptic ulcer disease, gastroparesis, or inflammatory disorders affecting the stomach.
- Bleeding disorders or active anticoagulation that cannot be safely paused for the procedure.
- Active substance use disorder, untreated eating disorders, or untreated severe psychiatric illness — these usually need to be stabilized first.
- Pregnancy, planned pregnancy within 12 months, or breastfeeding.
- Inability to tolerate general anesthesia or endoscopy.
Age and screening criteria
- Most programs treat adults ages 21 to 65, though some centers extend to age 18 or beyond 65 with additional clearance.
- Pre-procedure screening typically includes: a baseline endoscopy, lab work (CBC, metabolic panel, A1C, lipid panel, thyroid function), a nutrition consultation, and a behavioral health assessment.
- Candidates must be willing to commit to at least 12 months of follow-up visits, dietary changes, and supervised weight maintenance.
If your profile does not align with the typical ESG candidate, a GLP-1 medication, a gastric balloon, or bariatric surgery may be a better starting point to discuss with your care team. A structured medical weight loss program can also be a useful next step before any procedure.
Cost, access, and time commitment
Endoscopic sleeve gastroplasty is commonly a self-pay procedure, often $8,000 to $12,000 in the U.S. because many insurers still consider it investigational. That means you should expect to cover most of the cost up front.
Ongoing expenses include follow-up visits and nutrition coaching, which may be bundled or billed separately, plus optional meal replacements or protein supplements.
Endoscopic sleeve gastroplasty (ESG) is often considered investigational by insurers, so coverage is limited and prior authorization can be difficult. Many patients pay out of pocket, with typical pricing around $8,000 to $13,000 including facility and anesthesia fees.
To reduce costs, compare bundled self-pay packages, ask about financing plans, and use FSA/HSA funds for eligible portions of the procedure and follow-up visits. Clarify whether pre-op testing or nutrition counseling is included in the quoted price.
How to decide (decision checklist)
- Check BMI and goals. ESG fits best for people who want moderate weight loss without surgery.
- Compare to surgical options. If you want larger or more durable results and accept higher invasiveness, sleeve or bypass may be better.
- Compare to balloon or meds. If you want a temporary option, gastric balloon is another choice; medications can be used if you prefer no procedure.
- Confirm lifestyle readiness. ESG still requires strict nutrition changes and follow-up to maintain results.
Practical next steps
This week
- Verify eligibility (BMI range and health history) with an endoscopic bariatric program.
- Review the staged post-procedure diet and line up protein shakes and hydration options.
- Plan for a few days of reduced activity and someone to drive you home after the procedure.
What to track
- Nausea, reflux, and ability to meet protein/fluid goals.
- Weekly weight trend and waist measurements.
- Follow-up appointments for suture checks or nutrition coaching.
How to know it’s working
- You progress through diet stages without persistent vomiting.
- Appetite decreases and portion control improves.
- Weight loss reaches roughly 10–15% of body weight by 6–12 months.
Frequently asked questions
How is ESG different from sleeve gastrectomy? ESG uses internal sutures to shrink the stomach without removing tissue, while sleeve gastrectomy surgically removes part of the stomach. ESG is less invasive but may produce less weight loss.
Who is a good candidate for ESG? ESG is often considered for people with a BMI between 30 and 40 who want a minimally invasive option. Eligibility depends on medical history and goals.
How much weight can I expect to lose? Many people lose 15–20% of their total body weight in the first year when they follow a structured nutrition and activity plan.
Is ESG reversible? The sutures can be removed or revised in some cases, but ESG is generally intended to be a long-term intervention. Discuss reversibility with your provider.
What are the most common side effects? Nausea, cramping, and fatigue are common during the first week. Symptoms usually improve as the stomach heals and diet progresses.
Will I need vitamins after ESG? Because the intestines are not bypassed, nutrient absorption is largely unchanged. Still, many programs recommend a daily multivitamin due to reduced intake.
How long does the procedure take? ESG typically takes one to two hours, and most patients go home the same day. An overnight stay may be recommended in some cases.
Can I exercise after ESG? Light activity is encouraged soon after the procedure. More vigorous exercise usually resumes after two to four weeks, depending on your provider’s guidance.
Is ESG covered by insurance? Coverage varies and is less common than for bariatric surgery. Some patients pay out of pocket or use financing options.
What if I regain weight? Weight regain can occur if old habits return. Ongoing support, follow-up visits, and lifestyle adjustments can help maintain results. If suturing loosens or weight loss falls short, bariatric revision surgery is sometimes discussed as a next step.
How this compares to other options
- Compared with sleeve gastrectomy, ESG is less invasive but usually leads to less total weight loss.
- Compared with gastric balloon procedures, ESG is more permanent and can offer steadier results.
- Compared with adjustable gastric banding, ESG avoids implanted hardware and the periodic adjustments banding can require.
- Compared with GLP-1 medications, ESG is procedural but may reduce the need for long-term medication use.
Extra questions to consider
How do I know if this option fits my lifestyle? Look at your daily schedule, food preferences, travel routines, and stress levels. The best approach is one you can follow most days without constant friction. If an option feels overly restrictive or hard to sustain, discuss alternatives with your care team.
What should I track to know it is working? Track weight trends, measurements, and how you feel in daily life. Some people also monitor lab values, appetite, sleep quality, or exercise capacity. Choosing a few meaningful metrics helps you see progress even when the scale moves slowly.
Myths vs facts
- Myth: ESG is the same as a surgical sleeve. Fact: ESG uses sutures without removing stomach tissue and typically leads to less weight loss.
- Myth: ESG is permanent and cannot be revised. Fact: The sutures can loosen over time and revisions or repeat procedures may be needed.
- Myth: There is no follow-up required. Fact: ESG still needs dietary changes and structured follow-up to maintain results.
Experience-based scenarios
- You want a procedure without incisions and shorter downtime. ESG can be appealing if you want a less invasive option with a quicker return to work.
- You need the largest possible weight loss or have severe reflux. ESG typically delivers less weight loss than surgical bypass and may not help reflux, so another option may fit better.
How this article was researched
We reviewed peer-reviewed trials, systematic reviews, and clinical guidance on this topic, prioritizing high-quality human studies such as this publication and related evidence to summarize expected outcomes, safety considerations, and practical guidance.
ESG eligibility and results: quick answers
Who is a candidate for endoscopic sleeve gastroplasty?
A typical ESG candidate is an adult age 21 to 65 with a BMI between 30 and 40 who has tried and not maintained weight loss through diet, exercise, or prescription medications. Candidates need to be cleared on a baseline endoscopy, have no prior stomach surgery or large hiatal hernia, and be willing to commit to at least 12 months of nutrition follow-up. Patients with BMI 27 to 30 plus weight-related conditions like type 2 diabetes or hypertension may also qualify at some centers. See bariatric surgery overview for how ESG fits next to surgical options.
What BMI do you need for ESG?
Most U.S. programs treat patients with a BMI between 30 and 40. Some centers will treat BMI 27 to 30 if the patient has obesity-related conditions such as type 2 diabetes, sleep apnea, or hypertension. Patients with a BMI above 40 are not automatically excluded, but sleeve gastrectomy or gastric bypass is usually discussed first because it produces more weight loss. There is no single BMI cutoff used universally — eligibility also depends on prior weight loss history, overall health, and goals.
Is ESG covered by insurance?
Most U.S. private insurers still classify ESG as investigational and do not cover it, so the majority of patients pay out of pocket. Self-pay pricing typically runs $8,000 to $13,000 including the procedure, anesthesia, and facility fees. A small number of plans cover ESG when other options have failed, especially as more long-term data is published. FSA/HSA funds can usually be applied to eligible portions, and many programs offer financing. Coverage for follow-up visits, nutrition counseling, and lab work is more common than coverage for the procedure itself.
How much weight can you lose with ESG?
Across multiple trials and meta-analyses, patients lose about 15 to 20 percent of total body weight in the first 12 to 18 months, with most of the loss happening in the first six months. At two to three years, roughly 12 to 15 percent total body weight loss tends to be maintained when patients keep up nutrition follow-up and activity. Results are smaller than sleeve gastrectomy (typically 25 to 30 percent) and larger than most gastric balloon procedures. Individual outcomes vary based on starting BMI, adherence, and whether ESG is paired with GLP-1 medications or other support.
Sources
- Endoscopic sleeve gastroplasty for obesity: a multicenter study. Gastrointestinal Endoscopy (2017).
- Endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Endoscopy (2018).
- Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a systematic review and meta-analysis. Surgical Endoscopy (2020).